Company / Profit Margin
Arcadia Biosciences, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-139.5%
FY2025
5-year range
-313.9% / -57.9%
FY2021-FY2025
Trend
+55.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -2464.1% in FY2020 to -57.9% in FY2021.
Based on SEC 10-K filings.
-139.5% in FY2025 with a 5-year CAGR of +2324.6%.
Improved from -207.3% to -139.5% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +76.7pp
- 5-Year Change
- +2324.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 55.6% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -139.5% | +55.6% |
| FY2024 | -313.9% | -51.4% |
| FY2023 | -207.3% | +4.1% |
| FY2022 | -216.2% | -273.2% |
| FY2021 | -57.9% | +97.6% |
| FY2020 | -2464.1% | -167.6% |
| FY2019 | -920.8% | -136.0% |
| FY2018 | -390.1% | +36.6% |
| FY2017 | -615.6% | -85.6% |
| FY2016 | -331.7% | -26.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026